Eplivanserin
≥98%
- Product Code: 185737
CAS:
130579-75-8
| Molecular Weight: | 328.38 g./mol | Molecular Formula: | C₁₉H₂₁FN₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Eplivanserin is primarily investigated for its application in the treatment of insomnia, particularly in patients who have difficulty maintaining sleep throughout the night. It functions as a serotonin 5-HT2A receptor antagonist, which helps modulate neural activity involved in sleep regulation. By blocking these receptors, eplivanserin promotes deeper and more sustained sleep without the next-day sedative effects commonly seen with traditional hypnotics. It has been studied for use in both primary insomnia and sleep disturbances associated with psychiatric conditions like depression and schizophrenia. Due to its unique mechanism of action, it offers a potential alternative for patients who do not respond well to GABAergic sleep medications. Clinical development has focused on improving sleep architecture and minimizing dependency risks, making it a candidate for long-term management of chronic insomnia.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 G | 10-20 days | ฿12,350.00 |
+
-
|
| 0.010 G | 10-20 days | ฿41,680.00 |
+
-
|
| 0.005 G | 10-20 days | ฿27,790.00 |
+
-
|
Eplivanserin
Eplivanserin is primarily investigated for its application in the treatment of insomnia, particularly in patients who have difficulty maintaining sleep throughout the night. It functions as a serotonin 5-HT2A receptor antagonist, which helps modulate neural activity involved in sleep regulation. By blocking these receptors, eplivanserin promotes deeper and more sustained sleep without the next-day sedative effects commonly seen with traditional hypnotics. It has been studied for use in both primary insomnia and sleep disturbances associated with psychiatric conditions like depression and schizophrenia. Due to its unique mechanism of action, it offers a potential alternative for patients who do not respond well to GABAergic sleep medications. Clinical development has focused on improving sleep architecture and minimizing dependency risks, making it a candidate for long-term management of chronic insomnia.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :